
    
      Artificially ventilated patients on our intensive care unit will be monitored if specific
      biomarkers have a relevance in risk stratification, optimizing therapy, outcome and success
      in the process of weaning. Therefore, consecutively, specific blood parameters will be taken
      at time of intubation,day 1 of weaning and extubation.
    
  